Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fragile X messenger ribonucleoprotein 1 (FMRP) is an RNA-binding protein encoded by the FMR1 gene on the X chromosome, with critical roles in synaptic function, neuronal development, and cognitive processes. FMRP regulates the translation, transport, and localization of mRNAs, especially in neurons, where it is essential for normal synaptic plasticity. Loss or mutation of FMR1 causes fragile X syndrome, the most common inherited cause of intellectual disability, and is associated with a spectrum of neurodevelopmental and neurodegenerative disorders, including autism and premature ovarian failure. FMRP exerts translational repression on key targets involved in synaptic structure and function, influencing local protein synthesis in response to synaptic activity, with its activity tightly regulated by metabotropic glutamate receptor (mGluR) signaling.
Not applicable for direct targeting; when targeted indirectly, drugs modulate synaptic protein synthesis via mGluR signaling pathways affected by loss of FMRP function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fragile X messenger ribonucleoprotein 1 (FMRP).